No Detail Found!

Detection of Nodal Metastasis in Carcinoma Ovary on 18F Fluorodeoxyglucose Positron Emission Tomography- Computed Tomography Scan

Author(s)
Khadijah Shabbir Hussain Department of Allied Health Sciences Fatima Memorial Hospital, Lahore, Pakistan.
Sheikh Danial Hanan Department of Medical Imaging Technology, NUR International University, 17 KM Raiwind Rd, near Bahria Orchards, Central District Bahria Orchard, Lahore, Pakistan.
Nefal Numair Department of Allied Health Sciences Fatima Memorial Hospital, Lahore, Pakistan.
Rimsha Badar Department of Allied Health Sciences Fatima Memorial Hospital, Lahore, Pakistan.
Mahnam Khizer Department of Surgery, CMH Lahore Medical College, Abdul Rehman Rd, Sarwar Colony, Lahore, Pakistan.
Wardah Ashfaq Department of Nuclear Medicine and PET Imaging, Institute of Nuclear Medicine and Oncology, (INMOL) Khayaban-e-Jamia Punjab, Block D Muslim Town, Lahore, Pakistan.
Abubakar Imran Department of Allied Health Sciences Fatima Memorial Hospital, Lahore, Pakistan.
Abstract
Background: Ovarian carcinoma (OC) is the most common cause of gynecological cancer-associated death. PET-CT is used to investigate OC for local and distant metastases. Objective: This study characterized the anatomic distribution, metabolic, and morphologic status of lymph node metastasis (LNM) in OC and determined the frequency of LNM on an 18F FDG PET-CT scan. Methodology: 60 patients with OC who underwent an 18F-FDG PET-CT scan were included. The site, number of LNM, size of the largest node, and its metabolic uptake (SUVmax) were analyzed. Results: In 33/60 patients (55%), LNM was detected in one or more locations, and 27/60 (45%) patients did not show LNM. Out of 60 patients, 7 had abdominal, 7 had thoracic, 3 had pelvic, and 16 patients had more than one metastatic nodal site. The size of the largest node found in this study was 17.21 ±4.2 (range 11-27 mm) and the SUV was 4.14 ±0.76 (range 2.8-5.4). The results demonstrated that a large majority of the patients were detected with LNM at different sites that may upstage the patients and influence treatment outcomes. Conclusion: 18F FDG PET-CT demonstrated LNM in 33/60 (55%) of OC patients. We concluded that FDG PET-CT is a sensitive modality for the detection of LNM in OC.
Publication Details
Page(s) 54-59
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 2, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Ovarian carcinoma, Lymph node metastasis, 18F FDG PET-CT
References
Jayson G. C.,Kohn E. C.,Kitchener H. C.,Ledermann J. A. .2014 .. , 6736(13) : 62146-7.
Karst A. M.,Drapkin R.,Oncol J. .2010 .Ovarian Cancer Pathogenesis: A Model in Evolution,”. , : 1-13.
Tardieu A. .2021 .“Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. , : .
Kemppainen J.,Hynninen J.,Virtanen J.,Seppänen M. .2019 .PET/CT for Evaluation of Ovarian Cancer,”. Semin. Nucl. Med, 06(6) : 484-492.
Chen Y. W.,Lin C. Y.,Hou P. N.,Lee C. S.,Hou M. F.,Tsai E. M. .2011 .Whole-body FDG PET/CT in diagnosis of internal mammary nodal metastasis of ovarian carcinosarcoma. ” Clin. Nucl. Med, 36(6) : 460-461.
Budiana I. N. G.,Angelina M.,Pemayun T. G. A.,Turkish-German Gynecol T. G. A. .2018 .Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery. , 0119(1) : 47-54.
Lee S. I.,I. Vr S. I.,CT S. I. .2010 .PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization,” no. February, : 311-321.
Xue B.,Wang X. .2023 .Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer. ” Sci. Rep, 13(1) : 1-9.
Shaukat U,Rehman U,Numair Younis M . .. 5: e15274. DOI 10, 13 : .
J. Zhou .2016 .“Risk factors for lymph node metastasis in ovarian cancer: Implications for systematic lymphadenectomy. ” Int. J. Surg., 03 : 123-127.
.2019 .How to manage lymph nodes in ovarian cancer. ” Cancer, 125(S24) : 4573-4577.
J. Kemppainen J.,Hynninen J.,Virtanen M.,Seppänen M. .2019 .PET/CT for Evaluation of Ovarian Cancer,” Seminars in Nuclear Medicine. , 06 : 484-492.
.2021 .Globocan 2020 Pakistan report. , 928 : 2020-2021.
Orr B.,Edwards R. P.,Am Hematol. Oncol. Clin. North .2018 .Diagnosis and Treatment of Ovarian Cancer,”. , 07(6) : 943-964.
J. Hynninen .2012 .“FDG PET/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread,” Gynecol. , 04(1) : 64-68.
Ahmad Z. .2016 .Commonest cancers in Pakistan - findings and histopathological perspective from a premier surgical pathology center in Pakistan. March, 17 : 1061-1075.
Sultana N.,Shoukat S.,Nausheen S.,Memon B. .2020 .Diagnostic accuracy of PET / CT scan in evaluation of clinically suspected recurrent ovarian cancer,” no. April, : 156-160.
0

Citations

0

Downloads

14

Views